Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Does Leckrone benefit from a weak PTSC?

Finally, we agree on something.

As I stated previously, TPL has until September 30 to reach a settlement, or face the consequences of a trial. I don't see it going to trial either.

http://law.justia.com/california/codes/2009/pen/186.11.html

.

.

.

Be well

Share
New Message
Please login to post a reply